DIA 51th Annual Meeting, Washington, 14-18 June 2015

We’re heading to Barcelona for OCT 2026. And this time, we’re bringing a real story with us! Our colleague Evgeniya will be speaking alongside Jaume Costa from SOLTI, our dear client and long-term partner, about the question many teams still struggle with: Who should own your eClinical systems: sponsor or CRO? Stream B: AI & […]

Blinded studies are critical for maintaining the integrity of clinical trials. But while the concept is straightforward, the operational reality is often anything but. For many clinical teams, managing blinding means dealing with: This creates a constant burden: Even with strict processes in place, a single misconfiguration can compromise the entire study. TMF Blinding in […]

Financial management is critical because CROs must ensure that clinical trials remain within budget while generating expected revenue. Without proper financial oversight, organizations may experience delayed payments, incorrect invoicing, or reduced project profitability. A CTMS helps CROs maintain financial control and improve operational efficiency. Financial management is one of the most complex operational areas for […]

For decades, the clinical research industry operated under a manual, labor-intensive oversight model. The gold standard was 100% Source Data Verification (SDV) – a process where Clinical Research Associates (CRAs) traveled to sites to painstakingly cross-reference every data point in a Case Report Form against medical records. However, as trials have become more data-saturated and […]